About Torrent Pharmaceuticals Limited
Torrent Pharmaceuticals Limited (TORNTPHARM) has been publicly traded since 2002, making it a 24-year-old public company. It operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. The company is headquartered in Ahmedabad, India and employs approximately 17,059 people. With a market capitalization of $1.5 trillion, TORNTPHARM is one of the largest publicly traded companies.
Key Statistics
- Current Price
- ₹4,390.00
- Market Cap
- ₹1.49T
- 52-Week High
- ₹4,482.90
- 52-Week Low
- ₹3,038.40
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
₹1,000 Invested
Monthly Returns Heatmap
Annual Returns
| Year | Return | Start | End |
|---|---|---|---|
| 2026 | +14.81% | ₹3,823.78 | ₹4,390.00 |
| 2025 | +15.70% | ₹3,305.05 | ₹3,823.78 |
| 2024 | +47.26% | ₹2,244.32 | ₹3,305.05 |
| 2023 | +50.70% | ₹1,489.28 | ₹2,244.32 |
| 2022 | -3.73% | ₹1,546.96 | ₹1,489.28 |
| 2021 | +18.50% | ₹1,305.50 | ₹1,546.96 |
| 2020 | +54.06% | ₹847.41 | ₹1,305.50 |
| 2019 | +5.41% | ₹803.95 | ₹847.41 |
| 2018 | +26.09% | ₹637.60 | ₹803.95 |
| 2017 | +8.92% | ₹585.37 | ₹637.60 |
| 2016 | -6.77% | ₹627.91 | ₹585.37 |
| 2015 | +29.64% | ₹484.33 | ₹627.91 |
| 2014 | +143.37% | ₹199.01 | ₹484.33 |
| 2013 | +34.30% | ₹148.18 | ₹199.01 |
| 2012 | +36.17% | ₹108.82 | ₹148.18 |
| 2011 | -5.31% | ₹114.93 | ₹108.82 |
| 2010 | +48.31% | ₹77.49 | ₹114.93 |
| 2009 | +193.84% | ₹26.37 | ₹77.49 |
| 2008 | -30.32% | ₹37.85 | ₹26.37 |
| 2007 | -3.34% | ₹39.16 | ₹37.85 |
| 2006 | +1.69% | ₹38.51 | ₹39.16 |
| 2005 | +49.67% | ₹25.73 | ₹38.51 |
| 2004 | +45.76% | ₹17.65 | ₹25.73 |
| 2003 | +106.93% | ₹8.53 | ₹17.65 |
Valuation
TORNTPHARM currently trades at a trailing P/E ratio of 65.4, which is considered high relative to the broader market. The forward P/E of 68.8 suggests analysts expect earnings to be higher in the coming year. The price-to-book ratio stands at 17.6. The price-to-sales ratio is 11.7.
Dividends
Torrent Pharmaceuticals Limited pays a dividend to shareholders with a current yield of 0.80%. This translates to $35.00 per share annually. The payout ratio of 48% indicates sustainable dividend coverage.
Risk & Volatility
TORNTPHARM has a beta of 0.16, indicating it is less volatile than the overall market. The stock's 52-week range is $3038.40 to $4482.90, and it currently trades near its 52-week high.
Analyst Ratings
Based on 28 analyst opinions, TORNTPHARM has a consensus "buy" rating. The average price target of $4487.96 suggests 2.2% upside from current levels.
Frequently Asked Questions
What does Torrent Pharmaceuticals Limited do? ▼
Torrent Pharmaceuticals Limited is a Drug Manufacturers - Specialty & Generic company operating in the Healthcare sector. The company is headquartered in Ahmedabad, India.
What sector is TORNTPHARM in? ▼
TORNTPHARM operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
When did TORNTPHARM go public? ▼
Torrent Pharmaceuticals Limited went public in 2002, making it a 24-year-old public company as of 2026.
How much would $1,000 invested in TORNTPHARM 5 years ago be worth today? ▼
A $1,000 investment in TORNTPHARM five years ago would be worth approximately $3,650 today, representing a 265.0% return.
Does TORNTPHARM pay dividends? ▼
Yes, Torrent Pharmaceuticals Limited pays a dividend with a current yield of 0.80%, which is $35.0 per share annually.
What is TORNTPHARM's market cap? ▼
Torrent Pharmaceuticals Limited has a market capitalization of $1.5 trillion, classifying it as a mega-cap company.
What is TORNTPHARM's P/E ratio? ▼
TORNTPHARM has a trailing P/E ratio of 65.4 and a forward P/E of 68.8, which measures how much investors are paying per dollar of earnings.
Is TORNTPHARM a buy, hold, or sell? ▼
Based on 28 opinions, TORNTPHARM has a consensus "buy" rating. The average price target is $4487.96.
Last updated: 3/14/2026